On 2022-11-09, Clovis Oncology, Inc. (CLVSQ) announced earnings per share of $-0.39 for the fiscal quarter ending 2022-09-30, beating the average analyst estimate of $-0.42.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2022-11-09 | 2022-09-30 | $-0.42 | $-0.39 |
| 2022-08-08 | 2022-06-30 | $-0.42 | $-0.43 |
| 2022-05-04 | 2022-03-31 | $-0.43 | $-0.44 |
| 2022-02-23 | 2021-12-31 | $-0.60 | $-0.49 |
| 2021-11-03 | 2021-09-30 | $-0.48 | $-0.56 |
| 2021-08-04 | 2021-06-30 | $-0.57 | $-0.61 |
| 2021-05-05 | 2021-03-31 | $-0.72 | $-0.64 |
| 2021-02-23 | 2020-12-31 | $-0.76 | $-0.74 |
| 2020-11-05 | 2020-09-30 | $-1.01 | $-0.89 |
| 2020-08-06 | 2020-06-30 | $-1.02 | $-1.11 |
| 2020-05-05 | 2020-03-31 | $-1.29 | $-1.28 |
| 2020-02-24 | 2019-12-31 | $-1.61 | $-1.81 |
| 2019-11-07 | 2019-09-30 | $-1.92 | $-1.89 |
| 2019-08-01 | 2019-06-30 | $-1.70 | $-2.27 |
| 2019-05-07 | 2019-03-31 | $-1.80 | $-1.63 |
| 2019-02-26 | 2018-12-31 | $-1.68 | $-1.88 |
| 2018-10-30 | 2018-09-30 | $-1.60 | $-1.71 |
| 2018-08-01 | 2018-06-30 | $-1.38 | $-1.94 |
| 2018-05-08 | 2018-03-31 | $-1.34 | $-1.54 |
| 2018-02-26 | 2017-12-31 | $-1.28 | $-1.27 |
| 2017-11-01 | 2017-09-30 | $-1.16 | $-1.24 |
| 2017-08-02 | 2017-06-30 | $-1.27 | $-1.29 |
| 2017-05-03 | 2017-03-31 | $-1.43 | $-1.33 |
| 2017-02-22 | 2016-12-31 | $-1.65 | $-1.83 |
| 2016-11-03 | 2016-09-30 | $-1.89 | $-1.70 |
| 2016-08-08 | 2016-06-30 | $-2.09 | $-2.07 |
| 2016-05-05 | 2016-03-31 | $-2.15 | $-2.17 |
| 2016-02-25 | 2015-12-31 | $-2.39 | $-2.23 |
| 2015-11-05 | 2015-09-30 | $-1.98 | $-2.62 |
| 2015-08-06 | 2015-06-30 | $-2.11 | $-2.10 |
| 2015-05-06 | 2015-03-31 | $-1.78 | $-1.86 |
| 2015-02-25 | 2014-12-31 | $-1.41 | $-1.62 |